M S Penn

Summary

Publications

  1. doi request reprint Multimarker approach for identifying and documenting mitigation of cardiovascular risk
    Marc S Penn
    Cleveland Heart Lab, 6701 Carnegie Avenue, Cleveland, OH 44106, USA
    Future Cardiol 9:497-506. 2013
  2. doi request reprint Stem cells for myocardial regeneration
    M S Penn
    Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA
    Clin Pharmacol Ther 90:499-501. 2011
  3. ncbi request reprint Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway
    R G Salomon
    Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106 7078, USA
    Biochim Biophys Acta 1485:225-35. 2000
  4. ncbi request reprint Does coronary angiography before emergency aortic surgery affect in-hospital mortality?
    M S Penn
    Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA
    J Am Coll Cardiol 35:889-94. 2000
  5. ncbi request reprint Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention
    D P Chew
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 104:992-7. 2001
  6. ncbi request reprint Association between myeloperoxidase levels and risk of coronary artery disease
    R Zhang
    Department of Cell Biology, Cleveland Clinic Foundation, 9500 Euclid Ave, NC-10, Cleveland, OH 44195, USA
    JAMA 286:2136-42. 2001
  7. pmc Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure
    S Sundararaman
    Skirball Laboratory for Cardiovascular Cellular Therapeutics, Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Gene Ther 18:867-73. 2011

Collaborators

Detail Information

Publications7

  1. doi request reprint Multimarker approach for identifying and documenting mitigation of cardiovascular risk
    Marc S Penn
    Cleveland Heart Lab, 6701 Carnegie Avenue, Cleveland, OH 44106, USA
    Future Cardiol 9:497-506. 2013
    ..We discuss a novel multimarker panel for cardiovascular risk, define the differences between a multimarker approach and expensive amalgamations of multiple markers, and discuss how the field may develop in the future...
  2. doi request reprint Stem cells for myocardial regeneration
    M S Penn
    Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA
    Clin Pharmacol Ther 90:499-501. 2011
    ..In this brief review, we attempt to conceptualize the knowledge to date as well as examine how this knowledge has been translated to various therapeutic strategies...
  3. ncbi request reprint Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway
    R G Salomon
    Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106 7078, USA
    Biochim Biophys Acta 1485:225-35. 2000
    ..That isoLG-protein adduct levels are more strongly correlated with disease than are total cholesterol or apoB suggests an independent defect that results in an abnormally high level of oxidative injury associated with AS and RD...
  4. ncbi request reprint Does coronary angiography before emergency aortic surgery affect in-hospital mortality?
    M S Penn
    Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA
    J Am Coll Cardiol 35:889-94. 2000
    ..To study the relationship between coronary angiography and in-hospital mortality in patients undergoing emergency surgery of the aorta without a history of coronary revascularization or coronary angiography before the onset of symptoms...
  5. ncbi request reprint Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention
    D P Chew
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 104:992-7. 2001
    ..Coupled anatomic, clinical, and inflammatory risk stratification demonstrates strong predictive utility among patients undergoing percutaneous coronary intervention and may be useful for guiding future strategies...
  6. ncbi request reprint Association between myeloperoxidase levels and risk of coronary artery disease
    R Zhang
    Department of Cell Biology, Cleveland Clinic Foundation, 9500 Euclid Ave, NC-10, Cleveland, OH 44195, USA
    JAMA 286:2136-42. 2001
    ..These findings support a potential role for MPO as an inflammatory marker in CAD and may have implications for atherosclerosis diagnosis and risk assessment...
  7. pmc Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure
    S Sundararaman
    Skirball Laboratory for Cardiovascular Cellular Therapeutics, Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Gene Ther 18:867-73. 2011
    ..These data demonstrate that stand-alone non-viral hSDF-1 gene transfer is a strategy for improving cardiac function in ischemic cardiomyopathy...